泰林生物(300813) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥66,938,979.30, a decrease of 16.33% compared to ¥80,006,616.11 in the same period last year[5] - The net profit attributable to shareholders was ¥3,528,154.63, down 39.93% from ¥5,873,080.66 year-on-year[5] - Basic and diluted earnings per share were both ¥0.03, a decrease of 40.00% from ¥0.05 in the same period last year[5] - Net profit for the period was ¥3,327,916.52, down from ¥5,541,204.91, reflecting a decrease of approximately 40.0% year-over-year[21] - Total operating revenue decreased to ¥66,938,979.30 from ¥80,006,616.11, representing a decline of approximately 16.4% year-over-year[20] - Total operating costs decreased to ¥62,864,064.42 from ¥77,318,177.90, a reduction of about 18.6% year-over-year[20] Cash Flow - The net cash flow from operating activities was -¥10,737,521.27, representing a decline of 70.53% compared to -¥6,296,392.84 in the previous year[5] - Operating cash inflow for the current period was $70,093,446.06, down from $80,315,376.79 in the previous period, representing a decrease of approximately 27.5%[24] - Net cash outflow from operating activities was -$10,737,521.27, compared to -$6,296,392.84 in the previous period, indicating a worsening of cash flow by approximately 70.5%[25] - Cash inflow from investment activities significantly increased to $472,400,165.74 from $176,994,526.02, marking an increase of approximately 167.5%[25] - Cash outflow from investment activities totaled $379,891,445.61, up from $176,608,235.15, reflecting an increase of approximately 114.5%[25] - The net increase in cash and cash equivalents for the current period was $54,449,822.06, contrasting with a decrease of -$5,893,231.99 in the previous period[25] Assets and Liabilities - Total assets at the end of the reporting period were ¥939,019,323.84, down 2.18% from ¥959,907,928.07 at the end of the previous year[5] - Total liabilities decreased to ¥115,440,823.90 from ¥139,178,386.25, a reduction of approximately 17.0% year-over-year[18] - The company's cash and cash equivalents decreased from RMB 264,872,528.62 to RMB 210,343,842.89, reflecting a decline of approximately 20.5%[16] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 11,553[10] - The largest shareholder, Ye Daling, holds 47.71% of the shares, totaling 57,824,000 shares[10] - The company reported a total of 1,208,000 shares held in the repurchase special account, accounting for 0.9967% of the total share capital[12] - The company has a total of 14,456,000 shares held by its largest shareholder, representing a significant portion of the total shares[12] Strategic Initiatives - The company plans to repurchase shares at a price not exceeding RMB 27.56 per share, with a total fund amount between RMB 20 million and RMB 40 million[13] - The company has initiated an employee stock ownership plan for 2025, which was approved by the board on March 11, 2025[14] - The company plans to focus on market expansion and new product development to drive future growth[23] Other Financial Metrics - The weighted average return on equity was 0.43%, down from 0.90% in the same period last year[5] - The company reported a decrease in other income by 63.20%, from ¥3,397,440.67 to ¥1,250,110.86, primarily due to reduced government subsidies[8] - The company's total equity attributable to shareholders increased slightly to ¥823,578,499.94 from ¥820,050,345.31, indicating a stable equity position[18] - Research and development expenses remained stable at ¥14,934,663.08 compared to ¥14,896,419.24, indicating continued investment in innovation[21] - Accounts receivable increased from RMB 43,546,552.81 to RMB 44,473,461.20, showing a growth of about 2.1%[16] - Inventory decreased from RMB 144,134,014.09 to RMB 141,018,169.49, indicating a reduction of approximately 2.2%[16] - The company reported a significant increase in cash flow from investing activities, which amounted to ¥92,508,720.13, a rise of 23,847.94% compared to ¥386,290.87 in the previous year[8]